A team of researchers sought to evaluate the association between the Genomic Prostate Score and long-term outcomes in patients having undergone radical prostatectomy for prostate cancer.
Robotic-assisted radical prostatectomy is associated with higher costs than open radical prostatectomy at the index hospitalization for the surgery, but it is associated with less healthcare use during the 1 year after discharge.
Overall, Black and White men with metastatic castration-resistant prostate cancer had similar median overall survival times, according to a British study.
In a small phase 2 trial involving men with intermediate-risk prostate cancer, a single ultra-high dose of radiation was safe and comparable to curative hypofractionated stereotactic body radiation therapy in tumor control and quality-of-life measures.
In a propensity score-based study, prostate cryoablation added to androgen deprivation therapy (ADT) improved failure-free survival and survival without castration-resistant disease compared with ADT alone.
Men who take 5-alpha-reductase inhibitors while on active surveillance for prostate cancer are less likely to experience cancer progression, according to a new study
The goal of the TRANSFORMER study was to compare the effects of bipolar androgen therapy with enzalutamide in asymptomatic men with castration-resistant prostate cancer who have experienced disease progression while receiving treatment with abiraterone.
An analysis of data from the VA healthcare system revealed a gap in recommended assessments of cardiovascular risk factors among men with prostate cancer.
Primary focal and radiation therapy for prostate cancer are associated with different rates of perioperative complications and long-term urinary continence recovery.
Approved prostate cancer drug treatments including formulations and usual dosing.
